A novel flavonoid isolated from Sophora flavescens exhibited anti-angiogenesis activity, decreased VEGF expression and caused G0/G1 cell cycle arrest in vitro

Pharmazie

Volumn 68, Issue 5, 2013, Pages 369-375

  Zhang, Xiu Li ^a   Cao, Mei Ai ^b   Pu, Li Ping ^a   Huang, Shuang Sheng ^c   Gao, Qing Xiang ^a   Yuan, Cheng Shan ^a   Wang, Chun Ming ^a,b  

^a School of Life Sciences   (China)

^b LANZHOU UNIVERSITY   (China)

^c NORTH MINZU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

7,2',4' TRIIHYDROXY 5 METHOXY 8 DIMETHYLALLYL FLAVANONE; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; FLAVONOID; FREE RADICAL; SOPHORA FLAVESCENS EXTRACT; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; OXIDATIVE STRESS; PLANT ROOT; PROTEIN EXPRESSION; SOPHORA FLAVESCENS; UMBILICAL VEIN ENDOTHELIAL CELL;

ANGIOGENESIS INHIBITORS; ANTIOXIDANTS; CELL ADHESION; CELL CYCLE; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; DRUGS, CHINESE HERBAL; ENDOTHELIAL CELLS; FLAVONOIDS; G0 PHASE; G1 PHASE; HUMANS; MICROTUBULES; PLANT ROOTS; REACTIVE OXYGEN SPECIES; SOPHORA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84878396398     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2013.2845     Document Type: Article

References (34)

1. Albini A, Dell'Eva R, Vene R, Ferrari N, Buhler DR, Noonan DM, Fassina G (2006) Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kappaB and Akt as targets. FASEB J 20: 527-529. (Pubitemid 46671238)
2. Birt DF, Hendrich S, Wang W (2001) Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther 90: 157-177. (Pubitemid 32913477)
3. Chen J, Liu L, Hou R, Shao Z, Wu Y, Chen X, Zhou L (2011) Calycosin promotes proliferation of estrogen receptor-positive cells via estrogen receptors and ERK1/2 activation in vitro and in vivo. Cancer Lett 308: 144-151.
4. Chinese-Pharmacopoeia-Commission (2010)Kushen (Sophorae Flavescentis Radix). In: LI, Y., Zhao, Y.Y., Yu, H.P., Song, H.L. (Eds.), The People's Republic of China Pharmacopoeia. China Medical Science Press, Beijing, pp. 188-189.
5. 2 in rat heart endothelial cells. Free Rad Biol Med 25: 891-897. (Pubitemid 28538554)
6. Harborne JB, Williams CA (2000) Advances in flavonoid research since 1992. Phytochemistry 55: 481-504.
7. Ho JW, Ngan Hon PL, Chim WO (2009) Effects of oxymatrine from Ku Shen on cancer cells. Anticancer Agents Med Chem 9: 823-826.
8. Huang HL, Wang CM, Wang ZH, Yao MJ, Han GT, Yuan JC, Gao K, Yuan CS (2011) Tirucallane-type triterpenoids from Dysoxylum lenticellatum. J Nat Prod 74: 2235-2242.
9. Huang SS, Zheng RL (2006) Rosmarinic acid inhibits angiogenesis and its mechanism of action in vitro. Cancer Lett 239: 271-280.
10. Jin JH, Kim JS, Kang SS, Son KH, Chang HW, Kim HP (2010) Antiinflammatory and anti-arthritic activity of total flavonoids of the roots of Sophora flavescens. J Ethnopharmacol 127: 589-595.
11. Ko WG, Kang TH, Kim NY, Lee SJ, Kim YC, Ko GI, Ryu SY, Lee BH (2000) Lavandulylflavonoids: a new class of in vitro apoptogenic agents from Sophora flavescens. Toxicol In Vitro 14: 429-433. (Pubitemid 30646056)
12. Lam KH, Alex D, Lam IK, Tsui SK, Yang ZF, Lee SM (2011) Nobiletin, a polymethoxylated flavonoid from citrus, shows anti-angiogenic activity in a zebrafish in vivo model and HUVEC in vitro model. J Cell Biochem 112: 3313-3321.
13. Li PL, Wang CM, Zhanga ZX, Jia ZJ (2007) Five new eremophilane derivatives from Ligularia sagitta. Tetrahedron 63: 12665-12670.
14. Liang CZ, Zhang JK, Shi Z, Liu B, Shen CQ, Tao HM(2012) Matrine induces caspase-dependent apoptosis in human osteosarcoma cells in vitro and in vivo through the upregulation of Bax and Fas/FasL and downregulation of Bcl-2. Cancer Chemother Pharmacol 69: 317-331.
15. Liu XJ, Cao MA, Li WH, Shen CS, Yan SQ, Yuan CS (2010) Alkaloids from Sophora flavescens Aition. Fitoterapia 81: 524-527.
16. Luo H, Rankin GO, Liu L, Daddysman MK, Jiang BH, Chen YC (2009) Kaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cells. Nutr Cancer 61: 554-563.
17. Morley KL, Ferguson PJ, Koropatnick J (2007) Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells. Cancer Lett 251: 168-178. (Pubitemid 46589774)
18. Priyadarsini RV, Vinothini G, Murugan RS, Manikandan P, Nagini S (2011) The flavonoid quercetin modulates the hallmark capabilities of hamster buccal pouch tumors. Nutr Cancer 63: 218-226.
19. Sagar SM, Yance D, Wong RK (2006) Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 1. Curr Oncol 13: 14-26.
20. Shojaei F (2012) Anti-angiogenesis therapy in cancer: current challenges and future perspectives. Cancer Lett 320: 130-137.
21. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82: 1107- 1112. (Pubitemid 20213250)
22. Sun M, Cao H, Sun L, Dong S, Bian Y, Han J, Zhang L, Ren S, Hu Y, Liu C, Xu L, Liu P (2012) Antitumor activities of kushen: literature review. Evid Based Complement Alternat Med 373219.
23. Tsao R (2010) Chemistry and biochemistry of dietary polyphenols. Nutrients 2: 1231-1246.
24. Tsuda H, Ohshima Y, Nomoto H, Fujita K, Matsuda E, Iigo M, Takasuka N, Moore MA(2004) Cancer prevention by natural compounds. Drug Metab Pharmacokinet 19: 245-263.
25. Ushio-Fukai M, Nakamura Y (2008) Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett 266: 37-52. (Pubitemid 351753035)
26. Wang CM, Jia ZJ, Zheng RL (2007) The effect of 17 sesquiterpenes on cell viability and telomerase activity in the human ovarian cancer cell line HO-8910. Planta Med 73: 180-184.
27. Wang CM, Yang H, Wei YM, Jia ZJ, Zheng RL (2004) In vitro effects on proliferation, telomerase activity and apoptosis of an eremophilanoid sesquiterpene from Senecio oldhamianus maxim in cultured human tumor cell lines. Pharmazie 59: 802-806. (Pubitemid 39390254)
28. Wang W, Passaniti A (1999) Extracellular matrix inhibits apoptosis and enhances endothelial cell differentiation by a NfkappaB-dependent mechanism. J Cell Biochem 73: 321-331. (Pubitemid 29198007)
29. Williams RJ, Spencer JP (2012) Flavonoids, cognition, and dementia: Actions, mechanisms, and potential therapeutic utility for Alzheimer disease. Free Radic Biol Med 52: 35-45.
30. Wu QH, Wang CM, Cheng SG, Gao K (2004) Bieremoligularolide and eremoligularin, two novel sesquiterpenoids from Ligularia muliensis. Tetrahedron Letters 45: 8855-8858. (Pubitemid 39446201)
31. Yang X, Yang S, McKimmey C, Liu B, Edgerton SM, Bales W, Archer LT, Thor AD (2010) Genistein induces enhanced growth promotion in ER-positive/erbB-2- overexpressing breast cancers by ERerbB- 2 cross talk and p27/kip1 downregulation. Carcinogenesis 31: 695-702.
32. Yao H, Xu W, Shi X, Zhang Z (2011) Dietary flavonoids as cancer prevention agents. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 29: 1-31.
33. Zhang B, Liu ZY, Li YY, Luo Y, Liu ML, Dong HY, Wang YX, Liu Y, Zhao PT, Jin FG, Li ZC (2011) Antiinflammatory effects of matrine in LPS-induced acute lung injury in mice. Eur J Pharm Sci 44: 573-579.
34. Zhou H, Lutterodt H, Cheng Z, Yu LL (2009) Anti-Inflammatory and antiproliferative activities of trifolirhizin, a flavonoid from Sophora flavescens roots. J Agric Food Chem 57: 4580-4585.